Overview

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

Status:
Completed
Trial end date:
2009-03-10
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the pharmacokinetic profile, safety and efficacy in Parkinson's Disease patients.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole